(FN) Fabrinet - Ratings and Ratios
Optical Components, Transceivers, Lasers, Sensors, Optical Substrates
Dividends
Currently no dividends paid| Risk via 10d forecast | |
|---|---|
| Volatility | 61.6% |
| Value at Risk 5%th | 84.9% |
| Relative Tail Risk | -16.19% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.51 |
| Alpha | 89.83 |
| CAGR/Max DD | 1.57 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.456 |
| Beta | 1.803 |
| Beta Downside | 1.819 |
| Drawdowns 3y | |
|---|---|
| Max DD | 37.47% |
| Mean DD | 11.30% |
| Median DD | 9.80% |
Description: FN Fabrinet October 31, 2025
Fabrinet (NYSE:FN) is a contract manufacturer that specializes in high-precision optical, electro-mechanical, and electronic assemblies for customers across North America, Asia-Pacific, and Europe. Its service portfolio spans design-for-manufacturing, supply-chain management, PCB assembly, advanced packaging, integration, final testing, and delivery of complex optical components such as reconfigurable optical add-drop multiplexers (ROADMs), amplifiers, modulators, transceivers, tunable lasers, active optical cables, and a range of lasers and sensors for telecom, data-center, automotive, medical, and industrial applications.
Key quantitative touchpoints (FY 2023): revenue of roughly $1.1 billion, gross margin hovering near 30 %, and a backlog that grew ~12 % YoY, driven largely by rising demand for data-center interconnects and 5G-enabled transport networks. The global optical components market is projected to expand at a CAGR of ~7 % through 2029, while semiconductor-related CAPEX in the U.S. and Europe remains a primary macro driver for Fabrinet’s high-mix, high-value contracts. A notable risk is the ongoing semiconductor supply-chain tightening, which can compress lead times and pressure pricing for custom optical modules.
If you want a deeper, data-rich assessment of Fabrinet’s valuation dynamics, the ValueRay platform offers granular financial models and scenario analyses that can help you test the sensitivity of these drivers.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income (348.1m TTM) > 0 and > 6% of Revenue (6% = 215.6m TTM) |
| FCFTA 0.07 (>2.0%) and ΔFCFTA -5.38pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 46.02% (prev 51.07%; Δ -5.05pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.12 (>3.0%) and CFO 347.8m <= Net Income 348.1m (YES >=105%, WARN >=100%) |
| Net Debt (-299.8m) to EBITDA (431.4m) ratio: -0.70 <= 3.0 (WARN <= 3.5) |
| Current Ratio 2.83 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (36.1m) change vs 12m ago -0.85% (target <= -2.0% for YES) |
| Gross Margin 11.99% (prev 12.35%; Δ -0.36pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 131.9% (prev 123.1%; Δ 8.84pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| error: Interest Coverage Ratio cannot be calculated (needs EBITDA TTM and Interest Expense TTM) |
Altman Z'' 9.34
| (A) 0.55 = (Total Current Assets 2.56b - Total Current Liabilities 905.5m) / Total Assets 3.01b |
| (B) 0.73 = Retained Earnings (Balance) 2.19b / Total Assets 3.01b |
| (C) 0.14 = EBIT TTM 375.9m / Avg Total Assets 2.72b |
| (D) 2.32 = Book Value of Equity 2.20b / Total Liabilities 947.6m |
| Total Rating: 9.34 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 77.00
| 1. Piotroski 4.50pt |
| 2. FCF Yield 1.19% |
| 3. FCF Margin 5.60% |
| 4. Debt/Equity 0.00 |
| 5. Debt/Ebitda -0.70 |
| 6. ROIC - WACC (= 5.59)% |
| 7. RoE 17.87% |
| 8. Rev. Trend 98.14% |
| 9. EPS Trend 93.49% |
What is the price of FN shares?
Over the past week, the price has changed by +15.50%, over one month by +10.57%, over three months by +38.67% and over the past year by +120.94%.
Is FN a buy, sell or hold?
- Strong Buy: 3
- Buy: 2
- Hold: 4
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the FN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 479.3 | -7.2% |
| Analysts Target Price | 479.3 | -7.2% |
| ValueRay Target Price | 784.1 | 51.8% |
FN Fundamental Data Overview December 06, 2025
P/E Trailing = 48.587
P/S = 4.704
P/B = 7.6755
P/EG = 1.19
Beta = 1.05
Revenue TTM = 3.59b USD
EBIT TTM = 375.9m USD
EBITDA TTM = 431.4m USD
Long Term Debt = 5.16m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 1.86m USD (from shortTermDebt, last quarter)
Debt = 5.16m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -299.8m USD (from netDebt column, last quarter)
Enterprise Value = 16.90b USD (16.90b + Debt 5.16m - CCE 2.85m)
Interest Coverage Ratio = unknown (Ebit TTM 375.9m / Interest Expense TTM 0.0)
FCF Yield = 1.19% (FCF TTM 201.1m / Enterprise Value 16.90b)
FCF Margin = 5.60% (FCF TTM 201.1m / Revenue TTM 3.59b)
Net Margin = 9.69% (Net Income TTM 348.1m / Revenue TTM 3.59b)
Gross Margin = 11.99% ((Revenue TTM 3.59b - Cost of Revenue TTM 3.16b) / Revenue TTM)
Gross Margin QoQ = 11.90% (prev 12.23%)
Tobins Q-Ratio = 5.62 (Enterprise Value 16.90b / Total Assets 3.01b)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt 5.16m)
Taxrate = 5.42% (5.50m / 101.4m)
NOPAT = 355.5m (EBIT 375.9m * (1 - 5.42%))
Current Ratio = 2.83 (Total Current Assets 2.56b / Total Current Liabilities 905.5m)
Debt / Equity = 0.00 (Debt 5.16m / totalStockholderEquity, last quarter 2.06b)
Debt / EBITDA = -0.70 (Net Debt -299.8m / EBITDA 431.4m)
Debt / FCF = -1.49 (Net Debt -299.8m / FCF TTM 201.1m)
Total Stockholder Equity = 1.95b (last 4 quarters mean from totalStockholderEquity)
RoA = 11.57% (Net Income 348.1m / Total Assets 3.01b)
RoE = 17.87% (Net Income TTM 348.1m / Total Stockholder Equity 1.95b)
RoCE = 19.24% (EBIT 375.9m / Capital Employed (Equity 1.95b + L.T.Debt 5.16m))
RoIC = 18.24% (NOPAT 355.5m / Invested Capital 1.95b)
WACC = 12.66% (E(16.90b)/V(16.91b) * Re(12.66%) + D(5.16m)/V(16.91b) * Rd(0.0%) * (1-Tc(0.05)))
Discount Rate = 12.66% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -0.74%
[DCF Debug] Terminal Value 67.89% ; FCFE base≈238.4m ; Y1≈294.1m ; Y5≈501.7m
Fair Price DCF = 121.2 (DCF Value 4.34b / Shares Outstanding 35.8m; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: 93.49 | EPS CAGR: 19.44% | SUE: 1.09 | # QB: 1
Revenue Correlation: 98.14 | Revenue CAGR: 15.67% | SUE: 4.0 | # QB: 4
EPS next Quarter (2026-03-31): EPS=3.44 | Chg30d=+0.314 | Revisions Net=+7 | Analysts=7
EPS current Year (2026-06-30): EPS=13.24 | Chg30d=+0.996 | Revisions Net=+7 | Growth EPS=+30.2% | Growth Revenue=+27.9%
EPS next Year (2027-06-30): EPS=15.26 | Chg30d=+1.183 | Revisions Net=+5 | Growth EPS=+15.2% | Growth Revenue=+13.7%
Additional Sources for FN Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle